Purchase Order HT942525P0083
Award Date 9/25/25
Potential Completion Date 9/24/26
Potential Value $44K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
ABER PROV GRD, MD 21010, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $87,964.23 firm fixed price purchase order to Qiagen, LLC on September 30, 2025, for scientific equipment preventive maintenance services supporting the Center of Infectious Disease Research in Support of the Warfighter, with completion scheduled for September 29, 2030. The contract, issued without set-aside designation, will be performed in Silver Spring, Maryland, and covers maintenance services for the contractor's specialized molecular diagnostics and...
- This is a $97,350.04 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The contract is for QIAGEN EQUIPMENT MAINTENANCE SERVICES and has a period of performance through September 28, 2024. No set-aside designation was used. Qiagen is a major provider of sample and assay technologies to federal agencies, supporting programs related to biomedical research, public health, law enforcement, and healthcare. This...
- The Defense Health Agency awarded a firm-fixed-price purchase order worth $55,002.15 to Qiagen, LLC, a division of the international provider Qiagen N.V., for pathology consultation and laboratory equipment. This award is not associated with a set-aside program. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs through past prime and sub-contract awards, including DNA/RNA extraction kits,...
- This is a $13,858 firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian federal agency, to Qiagen, LLC, a foreign-owned for-profit manufacturer and global provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academic research. The contract is for the maintenance of QIAGEN laboratory equipment. It does not have a set-aside designation and has an ultimate completion date of May 14, 2028. Qiagen is a...
- The Defense Health Agency awarded a BPA call valued at $79,706.36 to Qiagen, LLC for customized reagents and consumables, with a completion date of October 11, 2025. This contract was awarded on a firm fixed price basis without a set-aside designation, allowing Qiagen to compete in the open federal marketplace. The place of performance is located in Germantown, Maryland, where Qiagen maintains its headquarters as a foreign-owned manufacturer specializing in molecular diagnostics and scientific...
- Qiagen, LLC was awarded a $17,393.80 firm fixed price delivery order by the Defense Health Agency to provide TEST KITS. Qiagen is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. No set-aside designation was applied to this award. Performance will take place in Germantown, Maryland through September 30, 2024. Qiagen holds several indefinite delivery contracts with federal agencies including...
- The Department of the Army Medical Command awarded a firm fixed-price purchase order contract to Qiagen, LLC, a division of the international medical diagnostics company Qiagen N.V. The contract, valued at $80,457.60, is for the supply of various QIAGEN laboratory supplies including DNA/RNA extraction kits, PCR reagents, and related equipment. This contract was awarded under an unrestricted solicitation and did not have a set-aside designation. Qiagen, as a manufacturer of these specialized...
- This federal contract award, valued at $44,765.50, was made by the Defense Health Agency (DHA) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract, which has no set-aside designation, is for the provision of QIASEQ FORCE products, which are likely targeted DNA panels and kits. The original solicitation, issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA), sought qualified sources capable of providing these specialized molecular...
- This is a $211,853.58 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, laboratory equipment, and bioinformatics software. The contract is for QCII ONE PRECUR 301-600 TESTING, with a period of performance through May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a significant federal contract portfolio supporting biomedical research,...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $49,060.00 firm fixed price purchase order to Qiagen, LLC, a division of the international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, for maintenance on laboratory equipment. The contract has a completion date of June 30, 2023 and was awarded on July 1, 2018. Qiagen has provided a range of goods and services to support federal...